Roche's Virtual Pipeline Event

Agenda:

Ophthalmology overview

BOULEVARD: Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema

Jason Ehrlich, M.D. Ph.D., Senior Group Medical Director, Ophthalmology

Sascha Fauser, M.D., Head pRED Ophthalmology

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018

Investors

Downloads

PDF